Home »
News & Insights »
China IPR News »
【Other】Shenzhen’s first drug safety civil public interest litigation with punitive damages claims opens trial. 4 people involved in manufacturing and selling counterfeit drugs face huge compensation.
【Other】Shenzhen’s first drug safety civil public interest litigation with punitive damages claims opens trial. 4 people involved in manufacturing and selling counterfeit drugs face huge compensation.